Veno-arterial extracorporeal membrane oxygenation support for cardiogenic shock secondary to immune checkpoint inhibitors

Quynh Nguyen, Hossein Shayan, Division of Cardiac Surgery, University of British Columbia, School of Biomedical Engineering, University of British Columbia, Royal Columbian Hospital, New Westminster

Perfusion

Published online on July 29, 2025

Abstract

Perfusion, Ahead of Print.
IntroductionTremelimumab in combination with Durvalumab has recently been approved for the treatment of unresectable hepatocellular carcinoma (HCC). While immune checkpoint inhibitors (ICIs) have transformed cancer therapy, they are associated with rare ...